Minolox-100 contains minocycline hydrochloride, a broad-spectrum tetracycline antibiotic that works by inhibiting bacterial protein synthesis, preventing the growth and replication of susceptible bacteria.

Minocycline is widely used in the treatment of respiratory infections, skin and soft tissue infections, Lyme disease, Mycoplasma infections, Chlamydia infections, and other bacterial conditions as determined by a healthcare professional.

Compared with many other antibiotics, minocycline demonstrates excellent tissue and intracellular penetration and has been studied for its potential anti-inflammatory and neuroprotective properties. Because of these characteristics, it is sometimes considered in protocols addressing chronic infections associated with persistent inflammation.

Within the Autism Navigator biological model, minocycline may be considered by prescribing physicians when laboratory findings and clinical evaluation suggest the presence of chronic bacterial infections that may contribute to immune dysregulation, inflammation, neuroinflammation, or related chronic health conditions.

Treatment decisions, dosage schedules, and duration of therapy should always be determined by a qualified healthcare professional.